Dr. Chantal A. El Amm, MD

Dr. El Amm practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. El Amm's NPI, 1104017383, was assigned on August 5, 2007. Dr. El Amm holds Ohio license 35-098037.

Dr. El Amm's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. El Amm's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. The medical group on file is University Hospitals Medical Practices.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Amm practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. El Amm's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. El Amm is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. El Amm's licenses on file in 3 states: Ohio, Minnesota and Texas.

CMS data shows 443 Medicare services from Dr. El Amm across 9 procedure codes in 2024, for 211 Medicare patients. Medicare paid $34,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Dr. El Amm in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Amm's median patient age at 68, with 51% women.

In 2024, Dr. El Amm wrote 1,032 Medicare Part D claims for 94 patients. 80% of them were for generic drugs. CMS names the drug for 899 of them, across 28 drugs with 11 or more claims each, at $208,138 in total drug cost. In 2023, CMS named 811 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. El Amm for performance year 2024, reported as part of a group. Dr. El Amm accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 286 general payments to Dr. El Amm from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Abbott Laboratories paid the most, $5,473.